| ONCT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ONCT shares outstanding history going back to 6/10/2019:
Also see: ONCT Market Cap History ONCT YTD Return |
ONCT Shares Outstanding History — Oncternal Therapeutics Share Count Over Time
As of 11/1/2024 Oncternal Therapeutics has 2.96 million ONCT shares outstanding. Investors often track the ONCT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ONCT share count trends over time, with 23 historical shares outstanding datapoints presented, dating back to 6/10/2019.
| ONCT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
ONCT Historical Shares Outstanding: +69.41% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| ONCT Stock Price Chart |
| About Oncternal Therapeutics Inc |
| Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. Co.'s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of advanced castration-resistant prostate cancer (CRPC) and other androgen receptor (AR) driven diseases. ONCT-808 is an autologous chimeric antigen receptor (CAR-T) therapy that targets ROR1 for the treatment of hematologic malignancies and solid tumors. We show 23 historical shares outstanding datapoints in our coverage of ONCT's shares outstanding history. Understanding the changing numbers of ONCT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ONCT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ONCT by allowing them to research ONCT shares outstanding history as well as any other stock in our coverage universe. |
| ONCT Current Stock Quote |
Quotes delayed 20 minutes  Free ONCT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ONCT Share Performance |
| Shares Outstanding Peers |
| Oncternal Therapeutics (ONCT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ONCY Shares Outstanding History ONEM Shares Outstanding History ONS Shares Outstanding History ONTX Shares Outstanding History ONVO Shares Outstanding History OPCH Shares Outstanding History OPGN Shares Outstanding History OPHT Shares Outstanding History OPK Shares Outstanding History OPNT Shares Outstanding History More Healthcare companies » |
ONCT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
